Fractures in The 340B Program

The 340B Program remains controversial. Hospitals and other Covered Entities (providers qualified to buy drugs at 340B prices) that benefit...

The Part D Squeeze

[DISCLAIMER: This isn’t a legal analysis. We’ve simplified provisions in the law where we could while still describing the intent...

Manufacturers Restricting 340B Sales to Contract Pharmacies

  • Abbvie
  • Amgen
  • AstraZeneca
  • Boehringer Ingelheim
  • Eli Lilly
  • Merck
  • Novartis
  • Novo Nordisk
  • Sanofi
  • UCB
  • United Therapeutics
  • and more…